Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating an investigational once-weekly injectable medication for weight management.
Obesity/Overweight Study
Age Range:
18
Gender:
Male and Female
Location:
Rochester, New York
About the Study
The purpose of this study is to better understand how well the investigational treatment works in reducing body weight, improving body composition and weight-related health measures, and evaluating its safety and tolerability. Researchers will also study whether the investigational medication may help delay progression to type 2 diabetes in participants with prediabetes.
Qualifications
Qualifications
You may be able to join if you:
-Are at least 18 years of age
-Have obesity with a body mass index (BMI) of 30 or greater
-Have had a stable body weight prior to screening
-Have a history of at least one unsuccessful dietary effort to reduce body weight
-Do not have type 2 diabetes
-Are willing and able to attend study visits and follow study procedures
FEATURED STUDIES
Adults 18 years and older may qualify for a study evaluating investigational treatment options for diabetic peripheral neuropathic pain (DPNP), […]
Adults 18 years and older may qualify for a study evaluating an investigational oral study medication for elevated lipoprotein(a) [Lp(a)], […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults living with obesity or overweight who do not have type 2 diabetes may qualify for a research study evaluating […]
Adults who are overweight or obese and currently using semaglutide (Ozempic®/Wegovy®) or tirzepatide (Mounjaro®/Zepbound®) may qualify for a research study […]
Adults 18 and older with obstructive sleep apnea (OSA) and overweight or obesity may qualify for a clinical study evaluating […]